会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
    • 药物组合物和抗肿瘤药物和其他感染性药物的方法
    • WO2006121895A3
    • 2007-06-07
    • PCT/US2006017482
    • 2006-05-04
    • LOS ANGELES BIOMED RES INSTEDWARDS JR JOHN EFILLER SCOTT GSHEPPARD DONALD CIBRAHIM ASHRAFFU YUESPELLBERG BRAD JYEAMAN MICHAEL
    • EDWARDS JR JOHN EFILLER SCOTT GSHEPPARD DONALD CIBRAHIM ASHRAFFU YUESPELLBERG BRAD JYEAMAN MICHAEL
    • A61K39/00A61K38/00
    • A61K39/0002A61K38/00A61K39/00A61K2039/505C07K14/40C07K16/14
    • The invention provides a vaccine including an isolated AIs protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically acceptable medium. The invention also provides a method of treating or preventing hematogenously disseminated or mucocutaneous candidiasis. The method includes administering an immunogenic amount of a vaccine an isolated AIs protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium. A method of treating or preventing disseminated candidiasis also is provided that includes administering an effective amount of an isolated AIs protein family member having cell adhesion activity, or an functional fragment thereof, to inhibit the binding or invasion of Candida to a host cell or tissue. The AIs protein family member can be derived from a Candida strain selected from the group consisting of Candida albicans, Candida krusei, Candida tropicalis, Candida glabrata and Candida parapsilosis and the AIs protein family member includes AIs Ip, Als3p, Als5p, AlsÌp, Als7p or Als9p. Also provided is a method of treating or preventing Staphylococcus aureus infections. The method includes administering an immunogenic amount of a vaccine an isolated AIs protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium.
    • 本发明提供一种包含具有细胞粘附活性的分离的AIs蛋白家族成员或其免疫原性片段的疫苗,其在药学上可接受的培养基中与佐剂一起使用。 本发明还提供了治疗或预防血液性弥漫性或粘膜皮肤念珠菌病的方法。 该方法包括在药学上可接受的培养基中施用免疫原性量的具有细胞粘附活性的分离的AIs蛋白质家族成员或其免疫原性片段。 还提供了治疗或预防弥漫性念珠菌病的方法,其包括施用有效量的具有细胞粘附活性的分离的AIs蛋白质家族成员或其功能片段,以抑制念珠菌与宿主细胞或组织的结合或侵入。 AIs蛋白质家族成员可以衍生自选自白色念珠菌,克罗斯假丝酵母,热带假丝酵母,光滑假丝酵母和副假丝酵母的念珠菌菌株,AIs蛋白家族成员包括AIs Ip,Als3p,Als5p,AlsIp,Als7p或 Als9p。 还提供了治疗或预防金黄色葡萄球菌感染的方法。 该方法包括在药学上可接受的培养基中施用免疫原性量的具有细胞粘附活性的分离的AIs蛋白质家族成员或其免疫原性片段。
    • 7. 发明申请
    • PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
    • 药物组合物和抗肿瘤药物和其他感染性药物的方法
    • WO2006121895A2
    • 2006-11-16
    • PCT/US2006/017482
    • 2006-05-04
    • LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTEREDWARDS, Jr., John, E.FILLER, Scott, G.SHEPPARD, Donald, C.IBRAHIM, AshrafFU, YueSPELLBERG, Brad, J.YEAMAN, Michael
    • EDWARDS, Jr., John, E.FILLER, Scott, G.SHEPPARD, Donald, C.IBRAHIM, AshrafFU, YueSPELLBERG, Brad, J.YEAMAN, Michael
    • A61K39/00C12N1/18
    • A61K39/0002A61K38/00A61K39/00A61K2039/505C07K14/40C07K16/14
    • The invention provides a vaccine including an isolated AIs protein family member having cell adhesion activity, or an immunogenic fragment thereof, with an adjuvant in a pharmaceutically acceptable medium. The invention also provides a method of treating or preventing hematogenously disseminated or mucocutaneous candidiasis. The method includes administering an immunogenic amount of a vaccine an isolated AIs protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium. A method of treating or preventing disseminated candidiasis also is provided that includes administering an effective amount of an isolated AIs protein family member having cell adhesion activity, or an functional fragment thereof, to inhibit the binding or invasion of Candida to a host cell or tissue. The AIs protein family member can be derived from a Candida strain selected from the group consisting of Candida albicans, Candida krusei, Candida tropicalis, Candida glabrata and Candida parapsilosis and the AIs protein family member includes AIs Ip, Als3p, Als5p, AlsÌp, Als7p or Als9p. Also provided is a method of treating or preventing Staphylococcus aureus infections. The method includes administering an immunogenic amount of a vaccine an isolated AIs protein family member having cell adhesion activity, or an immunogenic fragment thereof, in a pharmaceutically acceptable medium.
    • 本发明提供一种包含具有细胞粘附活性的分离的AIs蛋白家族成员或其免疫原性片段的疫苗,其在药学上可接受的培养基中与佐剂一起使用。 本发明还提供了治疗或预防血液性弥漫性或粘膜皮肤念珠菌病的方法。 该方法包括在药学上可接受的培养基中施用免疫原性量的具有细胞粘附活性的分离的AIs蛋白质家族成员或其免疫原性片段。 还提供了治疗或预防弥漫性念珠菌病的方法,其包括施用有效量的具有细胞粘附活性的分离的AIs蛋白质家族成员或其功能片段,以抑制念珠菌与宿主细胞或组织的结合或侵入。 AIs蛋白质家族成员可以衍生自选自白色念珠菌,克罗斯假丝酵母,热带假丝酵母,光滑假丝酵母和副假丝酵母的念珠菌菌株,AIs蛋白家族成员包括AIs Ip,Als3p,Als5p,AlsIp,Als7p或 Als9p。 还提供了治疗或预防金黄色葡萄球菌感染的方法。 该方法包括在药学上可接受的培养基中施用免疫原性量的具有细胞粘附活性的分离的AIs蛋白质家族成员或其免疫原性片段。